The company expired its plan on November 30, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
47.27 CNY | +1.03% | -2.82% | -14.02% |
Apr. 29 | Cathay Biotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 15 | Cathay Biotech's Q1 Profit to Surge Up to 100%, Revenue to Climb 43%; Shares Up 6% | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-14.02% | 3.79B | |
+13.72% | 28.4B | |
+11.79% | 1.79B | |
-10.77% | 637M | |
-27.39% | 390M | |
-81.65% | 216M | |
-17.50% | 106M |
- Stock Market
- Equities
- 688065 Stock
- News Cathay Biotech Inc.
- Cathay Biotech Inc.'s Equity Buyback announced on March 30, 2022, has expired with 1,133,035 shares, representing 0.19% for CNY 94.57 million.